Despite 3 in 4 of US adults starting their healthcare journey online, a study found only 8% of patients have ever used a Patient Support Program, and only 3% have downloaded a digital therapy solution.¹ There is a clear digital disconnect for the vast majority of patients, especially those who are underserved.
Twill partners with over 10 of the top 20 global pharmaceutical companies to address this issue by weaving together simpler, more comprehensive and connected support. Twill uses culturally-conscious content to recruit and engage diverse patient populations wherever they are in their care journey.
patients activated by Twill
on sponsored content (8x industry average)
on display ads
(>3x industry average)
31% of Twill users stay active after 24 months²
A study of Twill products showed active users experienced a 26% improvement in depression and anxiety symptoms over an 8 week period³
4x script conversion of Twill users to therapy vs. matched controls⁴
A recent study found 7% higher proportion of days covered for targeted therapies among Twill Care users than a matched comparator group⁵
10x ROI for partner engaging with Twill⁶
Sequences™ are our digital-led solutions designed to support the care journeys
of people with specific medical conditions and health needs.
Better management and support for people with chronic conditions within a scientifically designed, personalized, and digital-first care journey.
Our digital-first, clinically designed solution for mental health and well-being.
Our fully customizable, digital-led care solutions can be scaled to support many conditions, needs, and populations of any size.
Learn MoreSo far, Twill partners with over half of the top 20 global pharmaceutical companies. Find out how we can partner with you to transform patient behaviors, improve well-being, and increase your revenue.
Get behavioral data insights1. Phreesia 2021; Juniper Research 2022 2. Based on 100,739 B2B users of Happify, Twill’s wellness product vs 24 mos avg. user retention for Twitter 3.Twill Protocol HPY-HLS-21 4.External claims data analysis: compared Twill with a 1:1 matched control sample from general market; 95% confidence level. Considered gender, age, geography, diagnosis, and comorbidities to identify matched control. 5. Twill users had, on average, 7% higher proportion of days covered (+2.1 covered days per month) than a matched comparator group; third party analysis 6. Internal claims data analysis: assumes a $3.7M investment and an ASP of $6,300 per script